chevron_leftBack
As of 10 June 2026, Sam Chun Dang Pharm. Co., Ltd. has a market cap of $6.75B USD, ranking #3006 globally and #77 in South Korea.
It ranks #219 in the Healthcare sector, and #81 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$6.75BUSD
10.3T KRW
Enterprise Value
$6.77BUSD
10.33T KRW
Revenue (TTM)
$151.8MUSD
231.81B KRW
EBITDA (TTM)
$12.65MUSD
19.32B KRW
Net Income (TTM)
$3.45MUSD
5.26B KRW
EBITDA Margin
8.3%
Profit Margin
2.3%
PE Ratio
1958.1
PS Ratio
44.4
PB Ratio
28.3
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
422
Founded
1943
Website
scd.co.kr
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -6.2% | 9.9% | -60% | 0.8% | 103% | 219% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
000250
삼천당제약(주)
ISIN: KR7000250001
Shares Out.:
Shares Outstanding:
23.407M1
Shares Float:
14.405M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
415,500 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Sam Chun Dang Pharm. Co., Ltd.
Sam Chun Dang Pharm. Co., Ltd engages in the manufacturing and sale of pharmaceutical products in South Korea. It provides ethical and over the counter products in various therapeutic areas comprising ophthalmology, cardiovascular, endocrinology, antibacterial, anti-fungal, antiviral, respiratory, anti-inflammatory, antihistamine, and musculoskeletal products, as well as vitamins and gastro intestine products. The company is also involved in exporting activities. Sam Chun Dang Pharm. Co., Ltd was founded in 1943 and is headquartered in Seoul, South Korea.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 0126Z0
|
$9.11B
35%
13.91T KRW
|
-
|
|
KRX: 326030
|
$5.22B
-23%
7.97T KRW
|
29.9
|
|
KRX: 298380
|
$4.94B
-27%
7.55T KRW
|
-
|
|
KRX: 000100
|
$4.53B
-33%
6.92T KRW
|
35.9
|
|
KRX: 141080
|
$4.43B
-34%
6.76T KRW
|
-
|
|
KRX: 128940
|
$4.01B
-41%
6.12T KRW
|
36.1
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
11K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
8K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
5K%
|
97.4
|
|
SIX: RO
|
$321.17B
5K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$287.57B
4K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.35B
4K%
218.9B CHF
|
20.5
|
chevron_leftBack